- Home
- Personal stories
Personal stories
-
Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD. -
How Johnson & Johnson is advancing the fight against Alzheimer’s disease
After decades of commitment to understanding this neurodegenerative disease, company scientists have developed innovative therapies and tools that can potentially slow its progression and ease the psychological toll on patients and caretakers. A cure is still elusive—but preventing the disease may be within reach. -
What you need to know about Johnson & Johnson’s 2025 second-quarter earnings
Here’s an infographic breakdown of the company’s second-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses. -
Why helping the helpers is critical to disaster response
Health workers and first responders bear a double burden as survivors themselves, dealing with their own losses while helping their communities recover and rebuild in the aftermath of a disaster. -
Meet 3 Johnson & Johnson climate champions
As Johnson & Johnson continues to make progress toward meeting its climate goals, learn about some of the employees who are working to impact both human health and the health of the planet. -
Beyond capital: How J&J Impact Ventures is supporting SwipeRx to strengthen Southeast Asia’s vital pharmacy network
SwipeRx is equipping pharmacies in Southeast Asia to advance patient care and transform global health. J&J Impact Ventures, an investment fund within the J&J Foundation, provided SwipeRx tailored pro bono services from J&J employees, which has proven instrumental in shaping the company’s future. -
Johnson & Johnson brings New Jersey students to Washington, D.C. to build civic leadership
Eleven high school students from New Jersey—each representing a different congressional district—traveled to Washington, D.C., earlier this year to participate in the Close Up Foundation’s Washington, D.C. civic engagement program as Johnson & Johnson Scholars. -
Beyond capital: How J&J Impact Ventures is supporting Penda Health to provide tech-enabled, trust-based care in Kenya
In 2023, J&J Impact Ventures, an investment fund within J&J Foundation, invested in Penda Health to support and expand access to trustworthy, high-quality healthcare to communities in Kenya. Impact Ventures’ essential support included providing Penda Health with pro bono services from Johnson & Johnson employees with expertise and insights. -
-
What are clinical trials?
Behind every innovative medicine, treatment and therapy is a clinical trial. To help you understand them better, here’s a closer look at how they work.